📣 VC round data is live. Check it out!
- Public Comps
- Clarent
Clarent Valuation Multiples
Discover revenue and EBITDA valuation multiples for Clarent and similar public comparables like PMI Group, Brain+, Semantix, Premier Health Of America and more.
Clarent Overview
About Clarent
Clarent Corp operates under a liquidation plan of reorganization, which was confirmed by the bankruptcy court and became effective in April 2004.
Founded
1996
HQ

Employees
850
Website
Financials (FY)
EV
$492K
Valuation Multiples
Start free trialClarent Stock Performance
Clarent has current market cap of $492K, and enterprise value of $492K.
Clarent's stock price is $0.01.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $492K | $492K | 0.0% | — | — | — | — |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialClarent Valuation Multiples
Clarent Financial Valuation Multiples
As of May 10, 2026, Clarent has market cap of $492K and EV of $492K.
| LTM | Last FY | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Clarent Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Clarent Competitors
Clarent competitors include PMI Group, Brain+, Semantix, Premier Health Of America, Alternate Health, Monsenso, Telemedycyna Polska, Aino Health, Comintelli and 1933 Industries.
Most Clarent public comparables operate across Healthcare Software, BI & Analytics Software, B2B SaaS, Vertical SaaS, HealthTech and Horizontal SaaS.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| — | — | — | — | |||
| — | — | — | — | |||
| 0.0x | — | (0.0x) | — | |||
| 0.4x | 0.4x | (12.5x) | — | |||
| — | — | — | — | |||
| 1.6x | — | (4.9x) | — | |||
| 1.6x | — | (7.3x) | — | |||
| 1.2x | — | (13.0x) | — | |||
This data is available for Pro users. Sign up to see all Clarent competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Clarent
| When was Clarent founded? | Clarent was founded in 1996. |
| Where is Clarent headquartered? | Clarent is headquartered in United States. |
| How many employees does Clarent have? | As of today, Clarent has over 850 employees. |
| Is Clarent publicly listed? | Yes, Clarent is a public company listed on OTC Pink Sheets. |
| What is the stock symbol of Clarent? | Clarent trades under CLRN ticker. |
| Who are competitors of Clarent? | Clarent main competitors include PMI Group, Brain+, Semantix, Premier Health Of America, Alternate Health, Monsenso, Telemedycyna Polska, Aino Health, Comintelli, 1933 Industries. |
| What is the current market cap of Clarent? | Clarent's current market cap is $492K. |
| Is Clarent profitable? | No, Clarent is not profitable. |
| How many companies Clarent has acquired to date? | Clarent hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Clarent has invested to date? | Clarent hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Clarent
Lists including Clarent
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.